Home About CDC Press Room Funding A-Z Index Centers, Institute & Offices Training & Employment Contact Us
CDC Centers for Disease Control and Prevention Home Page
_  
 
Health & Safety TopicsPublications & ProductsData & StatisticsConferences & Events
 
Program Contents
bullet Programs
Contact Info

English and Spanish
(800) CDC-INFO
(800) 232-4636
TTY: (888) 232-6348
FAX: (770) 488-4760

International Travel
Phone: 1-887-394-8747
Contact CDC-INFO

Keep your kids healthy. cdc.gov/parents
 

Mycobacterium avium Complex

Disease Listing | General Information | Technical Information | Additional Information

Clinical Features Several different syndromes are caused by Mycobacterium avium complex (MAC). Disseminated infections are usually associated with HIV infection. Less commonly, pulmonary disease in nonimmunocompromised persons is a result of infection with MAC. In children, the most common syndrome is cervical lymphadenitis.
Etiologic Agent Mycobacterium avium complex (comprising M. avium and M.intracellulare).
Incidence Not reportable. Population-based data available for Houston and Atlanta metropolitan areas suggest a rate of 1/100,000/year. Incidence is decreasing among HIV- infected patients as a result of new treatment modalities e.g., combination therapy with nucleoside reverse transcriptase inhibitors and protease inhibitors, as well as antimycobacterial prophylaxis.
Sequelae In HIV infected persons, manifestations include night sweats, weight loss, abdominal pain, fatigue, diarrhea, and anemia.
Transmission Although the mode of transmission is unclear, MAC is most likely environmentally acquired.
Risk Groups HIV-infected persons. Rarely in children or nonimmuno-compromised persons.
Surveillance MAC is not nationally reportable. Currently under active surveillance in the Houston and Atlanta metropolitan areas.
Trends Incidence is decreasing because of changes in treatment for HIV-infected patients; however, antimicrobial resistance may be increasing.
Challenges Antimicrobial resistance and better treatment for affected persons. Unclear knowledge of acquisition of MAC from the environment.
Opportunities Reduction in MAC infection as a significant cause of morbidity and mortality in HIV-infected patients as a result of changes in available therapies.
 
 
Date: October 12, 2005
Content source: National Center for Immunization and Respiratory Diseases: Division of Bacterial Diseases
 
    Home   |   Policies and Regulations   |   Disclaimer   |   e-Government   |  FOIA   |  Contact Us  
Safer, Healthier People USA.govDHHS Department of Health
and Human Services
Centers for Disease Control and Prevention,1600 Clifton Rd, Atlanta, GA 30333, U.S.A
English and Spanish: (800) CDC-INFO / (800) 232-4636
TTY: (888) 232-6348 / FAX: (770) 488-4760